Market Cap 5.95M
Revenue (ttm) 0.00
Net Income (ttm) -5.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 33,200
Avg Vol 408,526
Day's Range N/A - N/A
Shares Out 3.39M
Stochastic %K 62%
Beta 1.48
Analysts Strong Sell
Price Target $48.98

Company Profile

Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. It also develops ENV 105, an antibody therapeutic that is in a Phase 2 clinical trial for prostate cancer patients resistant to androgen-targeted therapy, as well as in a Phase 1 clinical trial for non-smal...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 948 2356
Address:
2355 Westwood Blvd., Suite 139, Los Angeles, United States
StrawberryRips
StrawberryRips Sep. 12 at 12:13 AM
$KAPA def load time, post split banger soon
0 · Reply
Lyn30
Lyn30 Sep. 10 at 5:07 PM
$KAPA I may sell my shares to u to u and u cause I bought at low 😂
2 · Reply
Lyn30
Lyn30 Sep. 9 at 6:59 PM
$KAPA Post split stock I always wait 2 weeks to see color In the mean time already there mini run or dump a bit so big boys can load imo
0 · Reply
kairospharma
kairospharma Sep. 9 at 12:25 PM
@kairospharma's CEO and Chairman John Yu, M.D. will present a corporate overview at H.C. Wainwright & Co., LLC's 28th Annual Global Investment Conference in New York. Dr. Yu will also be available for one-on-one meetings throughout the conference. 📅: September 14, 2026 ⏰: 4:00 PM ET Read the full announcement: https://bit.ly/4gS30Ld $KAPA
0 · Reply
chazzalau
chazzalau Sep. 9 at 8:20 AM
$KAPA news soon 👀
0 · Reply
Lyn30
Lyn30 Sep. 9 at 6:09 AM
$KAPA Post split 3.9M Big data release in September Bio catalyst tiny float run huge normally Hope come out fat one 💰💰💰
0 · Reply
uptrend2025
uptrend2025 Sep. 8 at 6:16 PM
$KAPA 👀
0 · Reply
topstockalerts
topstockalerts Sep. 7 at 8:56 PM
$KAPA it just won’t sit still
0 · Reply
ewuzi01
ewuzi01 Sep. 5 at 4:29 PM
0 · Reply
Theman22
Theman22 Sep. 4 at 7:40 PM
$KAPA been watching for a long time and waiting. I’m in now. Let’s get it news soon. 
0 · Reply
Latest News on KAPA
Kairos Pharma announces 1-for-7 reverse stock split

2026-08-21T20:35:34.000Z - 23 days ago

Kairos Pharma announces 1-for-7 reverse stock split


Kairos Pharma Announces 1-for-7 Reverse Stock Split

Aug 21, 2026, 4:30 PM EDT - 23 days ago

Kairos Pharma Announces 1-for-7 Reverse Stock Split


Kairos Pharma Quarterly report: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 4 weeks ago

Kairos Pharma Quarterly report: Q2 2026


Kairos Pharma Transcript: AGM 2026

Jun 29, 2026, 12:00 PM EDT - 2 months ago

Kairos Pharma Transcript: AGM 2026


Kairos Pharma Proxy statement: Proxy filing

May 26, 2026, 8:00 AM EDT - 3 months ago

Kairos Pharma Proxy statement: Proxy filing


Kairos Pharma Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

Kairos Pharma Proxy statement: Proxy filing


Kairos Pharma Slides: Investor presentation

May 15, 2026, 7:00 AM EDT - 4 months ago

Kairos Pharma Slides: Investor presentation


Kairos Pharma Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 4 months ago

Kairos Pharma Quarterly report: Q1 2026


Kairos Pharma, Ltd. to Present at the LD Micro Invitational XVI

May 13, 2026, 5:30 AM EDT - 4 months ago

Kairos Pharma, Ltd. to Present at the LD Micro Invitational XVI


Kairos Pharma Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 4 months ago

Kairos Pharma Proxy statement: Proxy filing


Kairos Pharma Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 5 months ago

Kairos Pharma Annual report: Q4 2025


Kairos Pharma to acquire CL-273 from Celyn Therapeutics

2026-03-02T11:53:03.000Z - 6 months ago

Kairos Pharma to acquire CL-273 from Celyn Therapeutics


Kairos Pharma Registration statement: Registration Filing

Jan 13, 2026, 7:00 AM EST - 8 months ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma files $75M mixed securities shelf

2026-01-13T11:05:46.000Z - 8 months ago

Kairos Pharma files $75M mixed securities shelf


Kairos Pharma Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 10 months ago

Kairos Pharma Quarterly report: Q3 2025


Kairos Pharma Provides Shareholder Update

Nov 4, 2025, 8:00 AM EST - 10 months ago

Kairos Pharma Provides Shareholder Update


Kairos Pharma Transcript: Study Update

Sep 18, 2025, 5:00 PM EDT - 12 months ago

Kairos Pharma Transcript: Study Update


Kairos Pharma Press release: Study Update

Sep 18, 2025, 5:00 PM EDT - 12 months ago

Kairos Pharma Press release: Study Update


Kairos Pharma announces interim efficacy analysis of ENV105

2025-09-18T12:16:01.000Z - 12 months ago

Kairos Pharma announces interim efficacy analysis of ENV105


Kairos Pharma Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Kairos Pharma Quarterly report: Q2 2025


Kairos Pharma management to meet with Maxim

2025-08-04T14:05:21.000Z - 1 year ago

Kairos Pharma management to meet with Maxim


Why Is Kairos Pharma Stock (KAPA) Up 170% Today?

2025-07-16T01:26:00.000Z - 1 year ago

Why Is Kairos Pharma Stock (KAPA) Up 170% Today?


Kairos Pharma Proxy statement: Proxy Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Proxy statement: Proxy Filing


Kairos Pharma, Ltd. Announces Participation in the D.

May 6, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma, Ltd. Announces Participation in the D.


Kairos Pharma Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Proxy statement: Proxy Filing


Kairos Pharma Proxy statement: Proxy Filing

May 1, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Proxy statement: Proxy Filing


Kairos Pharma Ltd. Provides Letter to Stockholders

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Ltd. Provides Letter to Stockholders


Kairos Pharma Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Annual report: Q4 2024

Apr 14, 2025, 6:00 PM EDT - 1 year ago

Kairos Pharma Annual report: Q4 2024


Kairos Pharma initiated with a Buy at H.C. Wainwright

2025-04-03T10:16:23.000Z - 1 year ago

Kairos Pharma initiated with a Buy at H.C. Wainwright


Kairos Pharma completes safety lead-in of ENV105 trial

2025-03-31T11:11:12.000Z - 1 year ago

Kairos Pharma completes safety lead-in of ENV105 trial


Kairos Pharma initiated with a Buy at Maxim

2025-03-27T11:40:11.000Z - 1 year ago

Kairos Pharma initiated with a Buy at Maxim


Kairos Pharma announces new DoD funding for ENV205 research

2025-02-18T13:42:31.000Z - 1 year ago

Kairos Pharma announces new DoD funding for ENV205 research


Kairos Pharma Registration statement: Registration Filing

Jan 29, 2025, 7:00 AM EST - 1 year ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Provides Business Update and Outlook into 2025

Jan 21, 2025, 8:30 AM EST - 1 year ago

Kairos Pharma Provides Business Update and Outlook into 2025


IBN Initiates Coverage of Kairos Pharma Ltd.

Nov 26, 2024, 8:30 AM EST - 1 year ago

IBN Initiates Coverage of Kairos Pharma Ltd.


Kairos Pharma Quarterly report: Q3 2024

Nov 13, 2024, 6:00 PM EST - 1 year ago

Kairos Pharma Quarterly report: Q3 2024


Kairos Pharma Earnings release: Q3 2024

Nov 13, 2024, 6:00 PM EST - 1 year ago

Kairos Pharma Earnings release: Q3 2024


Kairos Pharma to Present at the LD Micro Main Event XVII

Oct 22, 2024, 9:00 AM EDT - 1 year ago

Kairos Pharma to Present at the LD Micro Main Event XVII


Kairos Pharma Closing of $6.2 Million Initial Public Offering

Sep 17, 2024, 4:29 PM EDT - 1 year ago

Kairos Pharma Closing of $6.2 Million Initial Public Offering


Kairos Pharma Prices $6.2 Million Initial Public Offering

Sep 16, 2024, 10:49 AM EDT - 1 year ago

Kairos Pharma Prices $6.2 Million Initial Public Offering


Kairos Pharma Registration statement: Registration Filing

Aug 16, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

Jun 4, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 20, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 13, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma Registration statement: Registration Filing

May 1, 2024, 8:00 AM EDT - 2 years ago

Kairos Pharma Registration statement: Registration Filing


Kairos Pharma to sell 1.55 million shares in IPO at $4 each

Feb 14, 2024, 6:16 PM EST - 2 years ago

Kairos Pharma to sell 1.55 million shares in IPO at $4 each


StrawberryRips
StrawberryRips Sep. 12 at 12:13 AM
$KAPA def load time, post split banger soon
0 · Reply
Lyn30
Lyn30 Sep. 10 at 5:07 PM
$KAPA I may sell my shares to u to u and u cause I bought at low 😂
2 · Reply
Lyn30
Lyn30 Sep. 9 at 6:59 PM
$KAPA Post split stock I always wait 2 weeks to see color In the mean time already there mini run or dump a bit so big boys can load imo
0 · Reply
kairospharma
kairospharma Sep. 9 at 12:25 PM
@kairospharma's CEO and Chairman John Yu, M.D. will present a corporate overview at H.C. Wainwright & Co., LLC's 28th Annual Global Investment Conference in New York. Dr. Yu will also be available for one-on-one meetings throughout the conference. 📅: September 14, 2026 ⏰: 4:00 PM ET Read the full announcement: https://bit.ly/4gS30Ld $KAPA
0 · Reply
chazzalau
chazzalau Sep. 9 at 8:20 AM
$KAPA news soon 👀
0 · Reply
Lyn30
Lyn30 Sep. 9 at 6:09 AM
$KAPA Post split 3.9M Big data release in September Bio catalyst tiny float run huge normally Hope come out fat one 💰💰💰
0 · Reply
uptrend2025
uptrend2025 Sep. 8 at 6:16 PM
$KAPA 👀
0 · Reply
topstockalerts
topstockalerts Sep. 7 at 8:56 PM
$KAPA it just won’t sit still
0 · Reply
ewuzi01
ewuzi01 Sep. 5 at 4:29 PM
0 · Reply
Theman22
Theman22 Sep. 4 at 7:40 PM
$KAPA been watching for a long time and waiting. I’m in now. Let’s get it news soon. 
0 · Reply
Lyn30
Lyn30 Sep. 3 at 5:41 PM
$KAPA Post split OS 3.93M float Analyst PT $49 Major data release this month
1 · Reply
OrangeJoolius
OrangeJoolius Sep. 2 at 4:01 PM
$KAPA Starter here.
0 · Reply
TwongStocks
TwongStocks Sep. 1 at 8:07 PM
Today's reverse split results. $FEED 1 for 12 Previous close $0.3501, $4.2012 split-adjusted Today's high $4.49 (premarket) Today's close $4.31 🟢Up 2.60% $FGL 1 for 100 Previous close $0.152, $15.20 split-adjusted Today's high $22.71 Today's close $17.23 🟢Up 13.36% $KAPA 1 for 7 Previous close $0.24, $1.68 split-adjusted Today's high $1.85 Today's close $1.65 🔴Down 1.79% $LGCL 1 for 125 Previous close $0.0351, $4.3875 split-adjusted Today's high $5.11 Today's close $4.35 🔴Down 0.85% $NIVF 1 for 3 Previous close $0.4497, $1.3491 split-adjusted Today's high $1.43 Today's close $1.33 🔴Down 1.42% I am not tracking any reverse splits on Wednesday or Thursday.
1 · Reply
Artadas
Artadas Sep. 1 at 3:13 PM
$KAPA its down around 30-40% from that post:) hard to calculate. Not buying it up here, will give it time to digest new price, easy can be below 1$ in 1 month
0 · Reply
Tunacanman69
Tunacanman69 Sep. 1 at 12:35 PM
$KAPA what’s the float size now ?
0 · Reply
TwongStocks
TwongStocks Sep. 1 at 11:19 AM
$FEED $FGL $LGCL $NIVF $KAPA All with reverse splits today, full details in the quoted post. Trading will resume at 9:00am ET, with the RS in effect.
0 · Reply
Disrupter
Disrupter Aug. 31 at 9:59 PM
$KAPA likely to rinse again through active ATM & ELOC after 1:7 R/S tomorrow
0 · Reply
TwongStocks
TwongStocks Aug. 31 at 8:24 PM
Tracking 5 stocks with reverse splits on Tuesday. Four on NASDAQ and one on the NYSE American. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am Tuesday morning. $FEED 1 for 12. Will reduce OS from approx 11.08m to approx 924k. $FGL 1 for 100. Will reduce outstanding Class A shares from approx 7.37m to approx 74k. NOTE: Nasdaq requires that companies maintain 500k publicly traded shares. I do not know if NASDAQ will let this RS through or if FGL plans to dilute before/after the RS to get the OS above 500k. $LGCL 1 for 125. Will reduce outstanding Class A shares from approx 42.79m to approx 342k. NOTE: Again, NASDAQ requires at least 500k publicly traded shares. LGCL has not published their share count since they announced an ATM on Aug 7. I do not know if they are still at 42.79m shares pre-split or they diluted heavily after the ATM. $NIVF 1 for 3. Will reduce OS from approx 6.31m to approx 2.10m. $KAPA 1 for 7. Will reduce OS from approx 23.7m to approx 3.39m.
4 · Reply
uptrend2025
uptrend2025 Aug. 31 at 12:39 PM
$KAPA Will it dip today or mañana? Looking to reenter as it will have news soon. Will buy a small position.
0 · Reply
StrawberryRips
StrawberryRips Aug. 28 at 9:51 PM
$KAPA👇 was waiting to say this but yeah mid/late September I’m looking to buy post RS
0 · Reply
JSP_Dilution_Player
JSP_Dilution_Player Aug. 28 at 1:24 PM
Below three stocks I am watching after r/s. Higher r/s ratio I avoid. $KAPA - low price after r/s makes me think management is confident in their catalysts $GOSS I want to see r/s before submission and low price after r/s 😉 $MREO after r/s into year end.
2 · Reply
TraderBuckNKY
TraderBuckNKY Aug. 26 at 7:21 PM
$KAPA volume!...something going on?...
0 · Reply